Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Majid Bahabadi"'
Autor:
Ali Zarei Mahmudabadi, Masoomeh Masoomi Karimi, Majid Bahabadi, Zahra Bagheri Hoseinabadi, Moslem JafariSaniKarimi, Reza Ahmadiadi
Publikováno v:
Cell Journal, Vol 18, Iss 3, Pp 381-388 (2016)
Objective: Vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) play important roles in angiogenesis of different developmental mechanisms such as wound healing, embryogenesis and diseases, including different types of cancer. VEGF
Externí odkaz:
https://doaj.org/article/e9d0cc0cf8394f729b5d5d1921e01f55
Autor:
Ali Zarei Mahmud abadi, Masoomeh Masoomi Karimi, Majid Bahabadi, Mahdi Kamali, Reza Kushki, Fariba Khalili, Nima Farhadi, Mostafa Naderi, Saman sajadi, Moslem Jafari Sani, Javad Alizadeh
Publikováno v:
مجله دانشگاه علوم پزشکی بیرجند, Vol 19, Iss 3, Pp 255-265 (2012)
Background and Aim: Angiogenesis is one of important biological processes any disruption in which leads to disease. The main signaling factor in this process is VEGF which acts through its receptors. The present study was done in order to inhibit the
Externí odkaz:
https://doaj.org/article/e7a0c3051120482ea3303a98386baede
Autor:
Iraj Khodadadi, Majid Bahabadi, Adel Mohammadalipour, Mohammad Taghi Goodarzi, Farjam Goudarzi, Arash Sarveazad
Publikováno v:
Free Radical Research. 52:763-774
Common protocols for chondrogenic differentiation of adipose-derived mesenchymal stem cells (ADSCs) are generally expensive and time-consuming and, so far, have not successfully recreated pure chondrocytes. We hypothesise that a low level of H2O2 may
Autor:
Mohammad Hashemnia, Ghasem Solgi, Jamshid Karimi, Adel Mohammadalipour, Iraj Khodadadi, Nasrin Sheikh, Majid Bahabadi
Publikováno v:
Immunopharmacology and Immunotoxicology. 39:19-27
SummaryObjectives: Dasatinib, a potent and broad-spectrum tyrosine kinase inhibitor, is approved for the treatment of imatinib-resistant chronic myelogenous leukemia. The aim of this study was to evaluate the anti-fibrotic, anti-inflammatory and anti
Autor:
Jamshid, Karimi, Adel, Mohammadalipour, Nasrin, Sheikh, Iraj, Khodadadi, Mohammad, Hashemnia, Farjam, Goudarzi, Vahid, Khanjarsim, Ghasem, Solgi, Mehrdad, Hajilooi, Majid, Bahabadi, Nejat, Kheiripour, Keshvad, Hedayatyanfard
Publikováno v:
Drug and chemical toxicology. 43(5)
Tyrosine kinase inhibitors (TKIs) have been developed as therapeutic compounds for inhibiting the progression of liver fibrosis. In the present study, the simultaneous treatment of Nilotinib (TKIs) and Losartan was studied. Forty rats were divided in
Autor:
Sheno Karimi, Iraj Khodadadi, Adel Mohammadalipour, Mohammad Taghi Goodarzi, Majid Bahabadi, Rezvan Mostoli, Farjam Goudarzi
Publikováno v:
Molecular biotechnology. 60(4)
Differentiation process of mesenchymal stem cells (MSCs) into adipocyte is involved in obesity. Multiple factors such as Ca2+ play important roles in different stages of this process. Because of the complicated roles of Ca2+ in adipogenesis, the aim
Autor:
Majid Bahabadi, Farjam Goudarzi, Iraj Khodadadi, Adel Mohammadalipour, Mohammad Hashemnia, Jamshid Karimi, Nasrin Sheikh, Ghasem Solgi
Publikováno v:
Immunopharmacology and immunotoxicology. 39(4)
The active ingredients of traditional medical herbs have been the focus of scientific interests.This study was designed to explore the mechanisms of actions of parthenolide on nonalcoholic fatty liver disease (NAFLD).Thirty-five male Wistar rats were
Autor:
Adel, Mohammadalipour, Jamshid, Karimi, Iraj, Khodadadi, Ghasem, Solgi, Mohammad, Hashemnia, Nasrin, Sheikh, Majid, Bahabadi
Publikováno v:
Immunopharmacology and immunotoxicology. 39(1)
Dasatinib, a potent and broad-spectrum tyrosine kinase inhibitor, is approved for the treatment of imatinib-resistant chronic myelogenous leukemia. The aim of this study was to evaluate the anti-fibrotic, anti-inflammatory and antioxidant effects of